Qiming U.S. Ventures Management, LLC - HILLEVAX INC ownership

HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 52 filers reported holding HILLEVAX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Qiming U.S. Ventures Management, LLC ownership history of HILLEVAX INC
ValueSharesWeighting
Q3 2023$7,517,514
-21.8%
558,9230.0%9.98%
-1.1%
Q2 2023$9,607,886
+4.0%
558,9230.0%10.10%
-9.7%
Q1 2023$9,238,997
-1.2%
558,9230.0%11.18%
-9.6%
Q4 2022$9,350,782
-2.1%
558,9230.0%12.37%
-10.9%
Q3 2022$9,552,000
+56.4%
558,9230.0%13.88%
+63.6%
Q2 2022$6,109,000558,9238.48%
Other shareholders
HILLEVAX INC shareholders Q3 2022
NameSharesValueWeighting ↓
Qiming U.S. Ventures Management, LLC 558,923$9,350,78212.37%
Frazier Life Sciences Management, L.P. 9,758,359$163,257,34610.15%
Abingworth LLP 1,838,486$30,757,87110.02%
Samsara BioCapital, LLC 610,062$10,206,3372.20%
StepStone Group LP 676,567$11,318,9661.48%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,694,101$45,072,3100.93%
BRAIDWELL LP 1,620,216$27,106,2140.91%
RA Capital Management 1,760,019$29,445,1180.60%
Perceptive Advisors 406,024$6,792,7820.19%
BVF INC/IL 248,579$4,158,7270.18%
View complete list of HILLEVAX INC shareholders